Results 101 to 110 of about 9,741 (153)

Secondary prevention of acute coronary syndromes: a summary of the new 2025 Australian guideline. [PDF]

Aust Prescr
Just J, Brieger D, Bennett A, Briffa T.
europepmc   +1 more source

Interaction of CYP2C19 with the effect of clopidogrel in secondary prevention of major ischemic events: Systematic review and meta-analysis. [PDF]

Int J Stroke
Kremers FC, van den Biggelaar J, Lingsma HF, van Schaik RH, Roozenbeek B, Dippel DW.   +5 more
europepmc   +1 more source

Differences in P2Y₁₂ Reaction Units Between Prasugrel and Clopidogrel by Ischemic Cerebrovascular Disease Subtypes　- Subanalysis From ACUTE-PRAS. [PDF]

Circ Rep
Fujimoto S, Iguchi Y, Yamagami H, Koga M, Itabashi R, Yakushiji Y, Kowata K, Kimura N, Terasawa Y, Shimizu T, Miyazaki Y, Oki K, Masuo O, Matsuoka H, Arakawa S, Ueda T, Tanaka R, Hashimoto W, Abe S, Kato G, Furugori T, Kimura K, ACUTE-PRAS Investigators.   +22 more
europepmc   +1 more source

The treatment of challenging visceral and peripheral arterial aneurysms with flow diversion-a German multicentric observational study. [PDF]

Front Med Technol
Schob S, Ukkat J, Scharf G, Maybaum Y, Tauber L, Lüdeke C, John E, Büchner KJ, Fiedler R, Frahm C, Wieprecht M, Brandt S, Alsabbagh M, Minasyan A, Simgen A, Brill R, Albrecht J, Wohlgemuth WA, de Bucourt M, Schüngel MS.   +19 more
europepmc   +1 more source

Hemorrhage Risk Associated with Anticoagulant and Antiplatelet Drug Combinations: Insights from the USFDA Adverse Event Reporting System. [PDF]

J Clin Med
Sridharan K, Sivaramakrishnan G.
europepmc   +1 more source

Clopidogrel versus aspirin monotherapy following dual antiplatelet therapy after percutaneous coronary intervention: an updated meta-analysis of 162,829 patients. [PDF]

Eur J Clin Pharmacol
Elbahloul MA, Mansour A, Galal A, Moawad WM, Khaled M, Kasem AW, Labeeb EE, Elgendy IY.   +7 more
europepmc   +1 more source

Unveiling the Hidden Risk: Ticagrelor-Induced Bradyarrhythmias and Conduction Complications in ACS Patients-Case Series. [PDF]

J Cardiovasc Dev Dis
Gorzynska-Schulz A, Stencelewski D, Daniłowicz-Szymanowicz L, Lica-Gorzynska M, Firkowska A, Wabich E.   +5 more
europepmc   +1 more source

The role of cangrelor in acute and high-risk PCI settings. [PDF]

Eur Heart J Cardiovasc Pharmacother
Zeymer U, Geisler T, Westermann D, Huber K.   +3 more
europepmc   +1 more source

Antiplatelet therapy and central nervous system hematomas: a cohort study using real-world data from the FAERS and VigiAccess databases. [PDF]

Int J Surg
Wang L, Cai H, Zhao S.
europepmc   +1 more source